R&D Grants for funding pharmaceutical research: Growing without ... Whilst equity investment is likely to be central to the funding strategy of many early-stage biotechs, grant funding can be a very useful alternative.
Events Partner Content 4th Annual PREDiCT Tumor Models San Francisco Serving the immuno-oncology scientific community
Partner Content Partner Content New collaboration will advance human-based drug evaluation Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.